|Outstanding shares||204.303,29 Euros|
|Nominal value||0,01 Euros|
|Outstanding capital||20.430.329 shares|
|Nominated advisor||Norgestión S.A.|
|Auditor||BDO Auditores S.L.|
Atrys Health S.A. has not distributed dividends since its incorporation.
Capital Increase, July 14th, 2016
Atrys Health conducted a capital increase of the company in the sum of 30,405.14 euros by issuing 3,040,541 new shares (0.01€ par value each), with a premium of 1.47 per share, making a total cash amount, including premium, of 4,500,000.68€.
The new issued shares are ordinary, equal to those currently outstanding, and give their holders from the date of registration in the accounting records of IBERCLEAR the same economic and political rights as the rest of outstanding shares.
As of today there are no publicly offered shares nor similar operations
Main Shareholders at July 25th 2016:
|Inveready Biotech II SCR||1.845.087||16,54%|
|Clear Image Corporate S.L.||1.646.270||14,76%|
|Corporación Inversora en Diagnóstico Virtual S.L.||40||11,01%|
|Reiman Inversiones S.L.||640.610||5,74%|
|Inveready Seed Capital SCR||536.147||4,81%|
|CECU INversiones S.L.||502.560||4,51%|
|Inveready Venture Finance||480.270||4,31%|
|Inveready Capital Company||394.538||3,54%|